BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,096 filers reported holding BAXTER INTL INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,396,216 | -17.6% | 142,984 | -0.6% | 0.66% | -13.7% |
| Q2 2023 | $6,552,257 | +16.4% | 143,816 | +3.6% | 0.76% | +10.1% |
| Q1 2023 | $5,630,580 | -16.0% | 138,821 | +5.6% | 0.69% | -10.0% |
| Q4 2022 | $6,699,089 | -9.6% | 131,432 | -4.5% | 0.77% | -24.5% |
| Q3 2022 | $7,411,000 | -4.5% | 137,589 | +13.8% | 1.02% | +1.8% |
| Q2 2022 | $7,763,000 | -9.2% | 120,864 | +9.6% | 1.00% | +1.7% |
| Q1 2022 | $8,552,000 | -7.7% | 110,289 | +2.2% | 0.98% | -5.4% |
| Q4 2021 | $9,267,000 | +8.1% | 107,958 | +1.3% | 1.04% | -0.8% |
| Q3 2021 | $8,571,000 | +4.7% | 106,568 | +4.8% | 1.04% | +8.5% |
| Q2 2021 | $8,189,000 | -1.5% | 101,722 | +3.2% | 0.96% | -10.0% |
| Q1 2021 | $8,316,000 | +7.8% | 98,602 | +2.5% | 1.07% | +1.8% |
| Q4 2020 | $7,716,000 | +0.8% | 96,167 | +1.0% | 1.05% | -8.8% |
| Q3 2020 | $7,657,000 | -7.8% | 95,211 | -1.3% | 1.15% | -13.0% |
| Q2 2020 | $8,309,000 | +4.8% | 96,506 | -1.2% | 1.32% | -8.3% |
| Q1 2020 | $7,927,000 | -3.1% | 97,641 | -0.2% | 1.44% | +20.7% |
| Q4 2019 | $8,180,000 | -5.1% | 97,829 | -0.7% | 1.20% | -8.9% |
| Q3 2019 | $8,617,000 | +5.6% | 98,519 | -1.1% | 1.31% | +3.7% |
| Q2 2019 | $8,161,000 | -0.1% | 99,644 | -0.8% | 1.27% | -2.1% |
| Q1 2019 | $8,166,000 | -21.8% | 100,429 | -36.7% | 1.29% | -15.5% |
| Q4 2018 | $10,444,000 | -11.5% | 158,674 | +3.7% | 1.53% | -1.8% |
| Q3 2018 | $11,799,000 | +4.2% | 153,049 | -0.2% | 1.56% | -4.6% |
| Q2 2018 | $11,318,000 | +19.4% | 153,284 | +5.2% | 1.64% | +14.2% |
| Q1 2018 | $9,480,000 | -99.9% | 145,749 | +9.1% | 1.43% | +4.9% |
| Q4 2017 | $8,632,000,000 | +100682.3% | 133,536 | -2.2% | 1.37% | -12.3% |
| Q3 2017 | $8,565,000 | +3.5% | 136,494 | -0.1% | 1.56% | -4.1% |
| Q2 2017 | $8,273,000 | +15.7% | 136,659 | -0.9% | 1.62% | +23.7% |
| Q1 2017 | $7,149,000 | +17.1% | 137,859 | +0.1% | 1.31% | +12.2% |
| Q4 2016 | $6,105,000 | -9.4% | 137,694 | -2.8% | 1.17% | -6.8% |
| Q3 2016 | $6,742,000 | +8.0% | 141,649 | +2.6% | 1.26% | +6.4% |
| Q2 2016 | $6,240,000 | +9.0% | 137,999 | -1.0% | 1.18% | +6.4% |
| Q1 2016 | $5,727,000 | +7.8% | 139,399 | +0.1% | 1.11% | -2.6% |
| Q4 2015 | $5,313,000 | +17.2% | 139,279 | +0.9% | 1.14% | +12.3% |
| Q3 2015 | $4,534,000 | -52.9% | 138,019 | +0.2% | 1.01% | -47.1% |
| Q2 2015 | $9,631,000 | +3.2% | 137,719 | +1.1% | 1.92% | +4.5% |
| Q1 2015 | $9,328,000 | -8.9% | 136,169 | -2.6% | 1.84% | -9.0% |
| Q4 2014 | $10,244,000 | +1.6% | 139,780 | -0.5% | 2.02% | -2.6% |
| Q3 2014 | $10,086,000 | -2.4% | 140,527 | -1.7% | 2.07% | -4.6% |
| Q2 2014 | $10,331,000 | +12.7% | 142,897 | +14.7% | 2.17% | +7.9% |
| Q1 2014 | $9,163,000 | +29.2% | 124,531 | +22.1% | 2.01% | +25.2% |
| Q4 2013 | $7,091,000 | +16.6% | 101,961 | +10.2% | 1.61% | +3.7% |
| Q3 2013 | $6,079,000 | -3.6% | 92,535 | +1.6% | 1.55% | -2.5% |
| Q2 2013 | $6,306,000 | – | 91,035 | – | 1.59% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
| Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
| FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
| Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
| Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
| Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
| York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
| First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
| SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
| Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |